1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Italy >
  5. AGC Biologics Acquires Molecular Medicine

M&A Deal Summary

AGC Biologics Acquires Molecular Medicine

On July 27, 2020, AGC Biologics acquired life science company Molecular Medicine

Acquisition Highlights
  • This is AGC Biologics’ 1st transaction in the Life Science sector.
  • This is AGC Biologics’ 1st transaction in Italy.

M&A Deal Summary
Date 2020-07-27
Target Molecular Medicine
Sector Life Science
Buyer(s) AGC Biologics
Deal Type Add-on Acquisition

Target

Molecular Medicine

Milano, Italy
Molecular Medicine SpA is a biotechnology company focused on research, development, production and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Molecular Medicine is based in Milano, Italy.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

AGC Biologics

Bothell, Washington, Denmark
Category Company
Sector Life Science
Revenue 2.0B USD (1970)
DESCRIPTION

AGC Biologics is a global contract manufacturing and development (CDMO) company for biopharmaceuticals. AGC Biologics is based in Bothell, Washington.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal